ClinVar Miner

Submissions for variant NM_000277.3(PAH):c.912+1G>A (rs62514956)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 9
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen PAH Variant Curation Expert Panel RCV000150083 SCV000852153 pathogenic Phenylketonuria 2018-08-10 reviewed by expert panel curation PAH-specific ACMG/AMP criteria applied: PM2: Extremely low frequency. ExAC MAF=0.00006.; PVS1: Canonical +1 splice site; PP4: Detected in 5 patients with classical PKU. (PMID:8659548). In summary this variant meets criteria to be classified as pathogenic for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PM2, PVS1, PP4).
EGL Genetic Diagnostics, Eurofins Clinical Diagnostics RCV000078537 SCV000110393 pathogenic not provided 2017-01-26 criteria provided, single submitter clinical testing
GeneDx RCV000078537 SCV000617699 pathogenic not provided 2020-04-22 criteria provided, single submitter clinical testing Canonical splice site variant predicted to result in a null allele in a gene for which loss-of-function is a known mechanism of disease; Not observed at a significant frequency in large population cohorts (Lek et al., 2016); Not associated with responsiveness to tetrahydrobiopterin (BH4) therapy (Sarkissian et al., 2012); This variant is associated with the following publications: (PMID: 25087612, 29316886, 12649065, 25525159, 24368688, 22841515, 26666653, 17502162, 23430918, 26350204, 29353259, 8659548, 30275481, 32668217)
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000150083 SCV000696471 pathogenic Phenylketonuria 2016-01-21 criteria provided, single submitter clinical testing Variant summary: This c.912+1G>A variant affects a conserved nucleotide in the canonical splice donor site at intron 8. Thus it is predicted to affect normal splicing (such as exon skipping), resulting in loss of function. Loss-of-function due to mutations in this gene is an established disease mechanism in Phenylketoneuria. 5/5 in silico programs via Alamut predict that this variant abrogates the splice donor site. This variant was found in 4/121156 control chromosomes (including broad and large populations from ExAC) at a frequency of 0.000033, which does not exceed the maximal expected frequency of a pathogenic allele (0.0079057) in this gene. This variant has been reported in several PKU patients, including patients with concordant recessive genotypes. One clinical lab and reputable databases have classified this variant as pathogenic. Taken together, this variant has been classified as a Pathogenic.
Invitae RCV000150083 SCV000939654 pathogenic Phenylketonuria 2020-09-30 criteria provided, single submitter clinical testing This sequence change affects a donor splice site in intron 8 of the PAH gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. This variant is present in population databases (rs62514956, ExAC 0.006%). Disruption of this splice site has been observed in combination with another PAH variant in individuals affected with phenylketonuria (PMID: 17502162, 26666653). ClinVar contains an entry for this variant (Variation ID: 92752). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies. Donor and acceptor splice site variants typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in PAH are known to be pathogenic (PMID: 1301187, 9634518). For these reasons, this variant has been classified as Pathogenic.
Baylor Genetics RCV000150083 SCV001163716 pathogenic Phenylketonuria criteria provided, single submitter clinical testing
DeBelle Laboratory for Biochemical Genetics, MUHC/MCH RESEARCH INSTITUTE RCV000078537 SCV000119767 not provided not provided no assertion provided not provided
Counsyl RCV000150083 SCV001132444 likely pathogenic Phenylketonuria 2014-01-02 no assertion criteria provided clinical testing
Natera, Inc. RCV000150083 SCV001463133 pathogenic Phenylketonuria 2020-09-16 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.